0000000000462603

AUTHOR

Nadine Cerf-bensussan

0000-0003-0665-1245

showing 3 related works from this author

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

2013

The Microbiota Makes for Good Therapy The gut microbiota has been implicated in the development of some cancers, such as colorectal cancer, but—given the important role our intestinal habitants play in metabolism—they may also modulate the efficacy of certain cancer therapeutics. Iida et al. (p. 967 ) evaluated the impact of the microbiota on the efficacy of an immunotherapy [CpG (the cytosine, guanosine, phosphodiester link) oligonucleotides] and oxaliplatin, a platinum compound used as a chemotherapeutic. Both therapies were reduced in efficacy in tumor-bearing mice that lacked microbiota, with the microbiota important for activating the innate immune response against the tumors. Viaud et…

Adoptive cell transferCyclophosphamidemedicine.drug_classLymphoid TissueGram-positive bacteria[SDV]Life Sciences [q-bio]AntibioticsAntineoplastic AgentsGut floraGram-Positive BacteriaArticle03 medical and health sciencesMice0302 clinical medicineImmune systemNeoplasmsIntestine SmallmedicineTumor MicroenvironmentGerm-Free LifeAnimalsCyclophosphamide030304 developmental biology0303 health sciencesMultidisciplinarybiology[ SDV ] Life Sciences [q-bio]Microbiotabiology.organism_classificationAdoptive TransferSmall intestine3. Good healthAnti-Bacterial AgentsIntestines[SDV] Life Sciences [q-bio]medicine.anatomical_structureLymphatic system030220 oncology & carcinogenesisBacterial TranslocationImmunologyCancer researchTh17 CellsImmunologic MemoryImmunosuppressive Agentsmedicine.drug
researchProduct

Review article: future research on coeliac disease - a position report from the European multistakeholder platform on coeliac disease (CDEUSSA)

2008

BACKGROUND: CDEUSSA is a Specific Support Action project from the Sixth Framework Programme Priority of the European Union (EU). Its aim is to bring together basic and applied research in the area of coeliac disease (CD). This paper reviews the main issues that are a result of the CDEUSSA initiative. AIM: To identify the major issues in need of investigation in the areas of clinical aspects, treatment, prevention and public health. METHODS: Key stakeholders, representing a wide range of knowledge with crucial importance for CD research and practice, have participated in two workshops aimed at identifying and proposing to the EU, as high priority research, topics in the areas of clinical asp…

Pediatricsmedicine.medical_specialtyBiomedical ResearchGlutensMEDLINEDiagnosis DifferentialQuality of life (healthcare)Settore MED/38 - Pediatria Generale E SpecialisticaEpidemiologymedicinemedia_common.cataloged_instanceHumansPharmacology (medical)Applied researchEuropean unionmedia_commonHepatologybusiness.industryPublic healthGastroenterologyPublic relationsReview articleNatural historyEuropeCeliac DiseasebusinessAlimentary pharmacology & therapeutics
researchProduct

A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult.

2019

International audience; Microbes colonize all body surfaces at birth and participate in the development of the immune system. In newborn mammals, the intestinal microbiota is first shaped by the dietary and immunological components of milk and then changes upon the introduction of solid food during weaning. Here, we explored the reactivity of the mouse intestinal immune system during the first weeks after birth and into adulthood. At weaning, the intestinal microbiota induced a vigorous immune response—a “weaning reaction”—that was programmed in time. Inhibition of the weaning reaction led to pathological imprinting and increased susceptibility to colitis, allergic inflammation, and cancer …

0301 basic medicinecolitis[SDV]Life Sciences [q-bio]short-chain fatty acidsImmunologyRetinoic acidTretinoinWeaningBiologyT-Lymphocytes Regulatoryregulatory T cellsAllergic inflammation03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineImmune systemRAR-related orphan receptor gammamicrobiotamedicineImmunology and AllergyWeaningAnimalsinflammatory pathologyColitisImprinting (psychology)Intestinal Mucosaneonatal periodNuclear Receptor Subfamily 1 Group F Member 3medicine.diseaseFatty Acids Volatile3. Good healthGastrointestinal Microbiome[SDV] Life Sciences [q-bio]Mice Inbred C57BL030104 developmental biologyInfectious DiseaseschemistryAnimals NewbornSolid food030220 oncology & carcinogenesisImmunologymucosal immunityImmunity
researchProduct